People with definite MS exhibited higher serum proportions of IgG3 (%IgG) and lower serum IgG2 levels than HC in the adjusted analysis, suggesting that these abnormalities are markers of B cell dysfunction associated with the immunopathogenesis of MS. This evidence concerns the gene IGHG3 and myeloid sarcoma.